Most bought healthcare stocks in Q4 2023
Discover which Healthcare stocks institutional investors added to most aggressively over Q4 2023 versus the prior calendar quarter in our filings. Notable additions at the top of this list include BAXTER INTERNATIONAL INC (BAX), AVANTOR INC (AVTR), RECURSION PHARMACEUTICALS-A (RXRX), ZIMMER BIOMET HOLDINGS INC (ZBH). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Net share increases
Top symbols by net quarter-over-quarter share change (increases).
Most bought stocks
Net quarter-over-quarter share increases across all institutional filers.
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BAX | BAXTER INTERNATIONAL INC | 36,136,398 | $1.4B | 0 | 7 | 3 | 1 | 13 |
| AVTR | AVANTOR INC | 35,023,526 | $1.0B | 0 | 4 | 1 | 2 | 8 |
| RXRX | RECURSION PHARMACEUTICALS-A | 13,802,950 | $151.3M | 1 | 1 | 0 | 0 | 2 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 6,879,509 | $892.8M | 0 | 8 | 4 | 0 | 13 |
| LFST | LIFESTANCE HEALTH GROUP INC | 6,001,312 | $49.6M | 0 | 1 | 0 | 1 | 1 |
| CVS | CVS HEALTH CORP | 5,264,762 | $643.6M | 4 | 7 | 8 | 1 | 21 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 4,355,211 | $89.5M | 0 | 1 | 0 | 1 | 2 |
| VTRS | VIATRIS INC | 3,435,728 | $39.8M | 2 | 1 | 3 | 0 | 9 |
| GEHC | GE HEALTHCARE TECHNOLOGY | 3,091,458 | $425.6M | 1 | 3 | 6 | 1 | 14 |
| BMY | BRISTOL-MYERS SQUIBB CO | 2,992,421 | -$94.6M | 2 | 10 | 4 | 1 | 20 |
| NVST | ENVISTA HOLDINGS CORP | 2,797,727 | $21.2M | 0 | 2 | 1 | 0 | 3 |
| DOCS | DOXIMITY INC-CLASS A | 2,251,920 | $56.6M | 2 | 2 | 1 | 0 | 5 |
| BLUE | BLUEBIRD BIO INC | 2,210,201 | -$238.0K | 1 | 2 | 0 | 0 | 3 |
| NVRO | NEVRO CORP | 2,197,547 | $46.7M | 1 | 1 | 0 | 0 | 2 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | 2,178,578 | -$451 | 0 | 1 | 0 | 1 | 2 |
| VERV | VERVE THERAPEUTICS INC | 1,989,116 | $29.0M | 1 | 1 | 0 | 0 | 2 |
| NKTR | NEKTAR THERAPEUTICS | 1,818,794 | -$25 | 0 | 1 | 0 | 0 | 2 |
| HLN | HALEON PLC-ADR | 1,804,981 | -$2.0M | 0 | 4 | 2 | 0 | 9 |
| RCM | R1 RCM INC | 1,799,098 | $19.0K | 1 | 0 | 0 | 0 | 1 |
| AKBA | AKEBIA THERAPEUTICS INC | 1,623,956 | $2.3K | 0 | 1 | 0 | 0 | 1 |
| HRTX | HERON THERAPEUTICS INC | 1,592,000 | $2.9K | 0 | 1 | 0 | 0 | 1 |
| ABT | ABBOTT LABORATORIES | 1,574,817 | $402.9M | 3 | 6 | 5 | 1 | 21 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1,563,251 | $161.2M | 2 | 2 | 2 | 0 | 6 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 1,553,135 | $9.1K | 0 | 1 | 0 | 0 | 1 |
| NTLA | INTELLIA THERAPEUTICS INC | 1,477,289 | $33.4M | 1 | 2 | 0 | 0 | 3 |
| JNJ | JOHNSON & JOHNSON | 1,453,037 | -$15.9M | 4 | 11 | 10 | 2 | 30 |
| DXCM | DEXCOM INC | 1,408,407 | $197.6M | 3 | 3 | 2 | 1 | 8 |
| ESPR | ESPERION THERAPEUTICS INC | 1,363,944 | $452.5K | 1 | 1 | 0 | 0 | 2 |
| TDOC | TELADOC HEALTH INC | 1,350,989 | $81.9M | 0 | 5 | 0 | 0 | 6 |
| BSX | BOSTON SCIENTIFIC CORP | 1,302,223 | $87.8M | 2 | 5 | 2 | 0 | 9 |
| ERAS | ERASCA INC | 1,266,400 | $2.8K | 0 | 1 | 0 | 0 | 1 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 1,246,005 | -$16.5M | 0 | 1 | 0 | 1 | 2 |
| PSNL | PERSONALIS INC | 1,240,454 | $7.1M | 0 | 2 | 0 | 0 | 2 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 1,233,977 | $720 | 0 | 1 | 0 | 0 | 1 |
| EW | EDWARDS LIFESCIENCES CORP | 1,197,763 | $139.0M | 2 | 5 | 2 | 2 | 10 |
| ACRS | ACLARIS THERAPEUTICS INC | 1,113,180 | $12.5K | 1 | 1 | 0 | 0 | 2 |
| NUVB | NUVATION BIO INC | 1,093,131 | $655.6K | 0 | 1 | 0 | 0 | 3 |
| TVTX | TRAVERE THERAPEUTICS INC | 1,086,892 | $9.9K | 0 | 1 | 0 | 0 | 1 |
| BFLY | BUTTERFLY NETWORK INC | 1,076,184 | -$147.1K | 0 | 4 | 0 | 0 | 4 |
| QSI | QUANTUM-SI INC | 1,074,905 | $7.2M | 0 | 2 | 0 | 0 | 2 |
| TXG | 10X GENOMICS INC-CLASS A | 1,044,242 | $102.6M | 0 | 1 | 1 | 0 | 3 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | 1,020,194 | $136.0M | 4 | 6 | 1 | 1 | 13 |
| GOSS | GOSSAMER BIO INC | 1,007,001 | $14.7K | 1 | 1 | 0 | 0 | 2 |
| BKD | BROOKDALE SENIOR LIVING INC | 966,993 | $2.6M | 0 | 2 | 0 | 0 | 2 |
| CDNA | CAREDX INC | 957,217 | $46.1M | 0 | 3 | 0 | 0 | 3 |
| HCA | HCA HEALTHCARE INC | 953,163 | $398.7M | 4 | 3 | 3 | 1 | 10 |
| MCK | MCKESSON CORP | 932,230 | $506.6M | 4 | 4 | 3 | 1 | 11 |
| OGN | ORGANON & CO | 917,948 | $2.6M | 1 | 2 | 1 | 3 | 6 |
| SENS | SENSEONICS HOLDINGS INC | 912,100 | $520 | 1 | 0 | 0 | 0 | 1 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 886,636 | $2.5M | 0 | 2 | 0 | 0 | 2 |